These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21963837)

  • 1. A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control.
    Sprague RS; Bowles EA; Achilleus D; Stephenson AH; Ellis CG; Ellsworth ML
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2466-72. PubMed ID: 21963837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle.
    Sprague RS; Goldman D; Bowles EA; Achilleus D; Stephenson AH; Ellis CG; Ellsworth ML
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H566-73. PubMed ID: 20511412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.
    Hanson MS; Stephenson AH; Bowles EA; Sprague RS
    Exp Biol Med (Maywood); 2010 Feb; 235(2):256-62. PubMed ID: 20404042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension.
    Sprague RS; Hanson MS; Achilleus D; Bowles EA; Stephenson AH; Sridharan M; Adderley S; Procknow J; Ellsworth ML
    Pharmacol Rep; 2009; 61(1):183-90. PubMed ID: 19307706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implication for vascular control.
    Hanson MS; Ellsworth ML; Achilleus D; Stephenson AH; Bowles EA; Sridharan M; Adderley S; Sprague RS
    Microcirculation; 2009 Jul; 16(5):424-33. PubMed ID: 19412833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle.
    Sprague RS; Bowles EA; Achilleus D; Ellsworth ML
    Acta Physiol (Oxf); 2011 Jul; 202(3):285-92. PubMed ID: 20731624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.
    Richards JP; Bowles EA; Gordon WR; Ellsworth ML; Stephenson AH; Sprague RS
    Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R411-8. PubMed ID: 25552662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilation of porcine retinal arterioles to cilostazol: roles of eNOS phosphorylation via cAMP/protein kinase A and AMP-activated protein kinase and potassium channels.
    Tanano I; Nagaoka T; Omae T; Ishibazawa A; Kamiya T; Ono S; Yoshida A
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1443-9. PubMed ID: 23341020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes.
    Dergunov SA; Bowles EA; Gordon W; Green M; Bierman A; Ellsworth ML; Pinkhassik E; Sprague RS
    Biochem Biophys Rep; 2015 Jul; 2():137-142. PubMed ID: 29124155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.
    Hanson MS; Stephenson AH; Bowles EA; Sridharan M; Adderley S; Sprague RS
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H786-93. PubMed ID: 18586889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
    Nakamura K; Ikomi F; Ohhashi T
    J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cilostazol, a selective cyclic AMP phosphodiesterase inhibitor on isolated rabbit spinal arterioles.
    Yashiro Y; Ohhashi T
    Jpn J Physiol; 2002 Oct; 52(5):471-7. PubMed ID: 12533252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rho kinase inhibitor Y-27632 increases erythrocyte deformability and low oxygen tension-induced ATP release.
    Thuet KM; Bowles EA; Ellsworth ML; Sprague RS; Stephenson AH
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1891-6. PubMed ID: 21890695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.
    Adderley SP; Dufaux EA; Sridharan M; Bowles EA; Hanson MS; Stephenson AH; Ellsworth ML; Sprague RS
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1617-24. PubMed ID: 19252089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.
    Sprague RS; Ellsworth ML
    Microcirculation; 2012 Jul; 19(5):430-9. PubMed ID: 22775760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release.
    Sridharan M; Sprague RS; Adderley SP; Bowles EA; Ellsworth ML; Stephenson AH
    Exp Biol Med (Maywood); 2010 Sep; 235(9):1142-8. PubMed ID: 20682601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release.
    Sprague RS; Stephenson AH; Bowles EA; Stumpf MS; Lonigro AJ
    Diabetes; 2006 Dec; 55(12):3588-93. PubMed ID: 17130508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
    Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
    Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.
    Clapp KM; Ellsworth ML; Sprague RS; Stephenson AH
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H660-6. PubMed ID: 23335799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
    Hashimoto A; Tanaka M; Takeda S; Ito H; Nagano K
    PLoS One; 2015; 10(7):e0132835. PubMed ID: 26181635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.